Advertisement
Advertisement
U.S. Markets close in 5 hrs 38 mins
Advertisement
Advertisement
Advertisement
Advertisement

Cosmos Holdings Inc. (COSM)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
3.4500+0.0100 (+0.29%)
As of 09:39AM EST. Market open.
Advertisement

Cosmos Holdings Inc.

141 West Jackson Boulevard
Suite 4236
Chicago, IL 60604
United States
312 536 3102
http://www.cosmosholdingsinc.com

Sector(s)Healthcare
IndustryDrug Manufacturers—Specialty & Generic
Full Time Employees89

Key Executives

NameTitlePayExercisedYear Born
Mr. Grigorios SiokasChairman & CEON/AN/A1965
Mr. Georgios TerzisChief Financial Officer44.64kN/A1982
Mr. Pavlos IgnatiadesCOO & DirectorN/AN/A1963
Mr. Peter Joseph GoldsteinExec. DirectorN/AN/A1963
Mr. Demetrios G. DemetriadesSec. & Independent DirectorN/AN/A1966
Amounts are as of December 31, 2020 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Cosmos Holdings Inc. operates as a vertically integrated pharmaceutical company. It offers proprietary line of branded and generic pharmaceuticals, nutraceuticals, OTC medications, and medical devices with EU distribution network. The company identifies, acquires, develops, and commercializes products that enhance patients' lives and outcomes and has a network of clients in Germany, the United Kingdom, the United Arab Emirates, Denmark, Italy, France, Singapore, Ireland, Sweden, Poland, the Netherlands, and Greece, as well as has distribution centers in Thessaloniki, Greece, Athens, Greece and Harlow, the United Kingdom. The company was formerly known as Prime Estates and Developments, Inc. and changed its name to Cosmos Holdings Inc. in November 2013. Cosmos Holdings Inc. was incorporated in 2009 and is based in Chicago, Illinois.

Corporate Governance

Cosmos Holdings Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Advertisement
Advertisement